Last reviewed · How we verify
NCT06837545
Uric Acid and Surgical Prognosis
trial testing No Intervention (Observational Study) in Uric Acid in 309,353 participants. Completed in 2 January 2025.
20 December 2024
Quick facts
| Lead sponsor | Asan Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 309,353 |
| Start date | 30 July 2024 |
| Primary completion | 20 December 2024 |
| Estimated completion | 2 January 2025 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- No Intervention (Observational Study) — full drug profile →
Conditions studied
- Uric Acid — all drugs for Uric Acid →
Sponsor
Asan Medical Center
Who can join
18 and older, any sex, with Uric Acid. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Preoperative serum uric acid significantly impacted mortality and morbidity in non-cardiac surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06837545
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No Intervention (Observational Study)
Trials testing the same drug.
- NCT07501871 — Digital Media Use and Treatment Adherence in Chemotherapy Patients · not yet recruiting
- NCT07340866 — Physical Fatigue, Compassion Fatigue, and Quiet Quitting in Physiotherapists · not yet recruiting
- NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
- NCT07351617 — Turkish Version of the Pain Metacognitions Questionnaire · not yet recruiting
- NCT07306858 — CT-Based Deep Learning for Differentiating Acute and Chronic Osteoporotic Vertebral Compression Fractures · not yet recruiting
Other recruiting trials for Uric Acid
Currently open trials in the same condition.
- NCT05943821 — The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with Cardiovascular Risk · Phase 3 · recruiting
Other Asan Medical Center trials
Trials by the same sponsor.
- NCT07530393 — Blood Viscosity and Outcomes After Elective Craniotomy · not yet recruiting
- NCT07010497 — A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Be · Phase 2 · recruiting
- NCT07382505 — Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cerv · not yet recruiting
- NCT07489092 — Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge · NA · recruiting
- NCT07431762 — Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Hear · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06837545 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Asan Medical Center
- Last refreshed: 20 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06837545.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing